Tocilizumab not associated with increased infection risk after CAR T-cell therapy: implications for COVID-19? is a research paper published in UNC Libraries (2024). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 2U24CA076518-16
A Data Resource for Analyzing Blood and Marrow Transplants
National Institutes of Health
Grant: 1U24CA233032-01
Immuno-Oncology Translation Network (IOTN): Cellular Immunotherapy Data Resource (CIDR)
National Institutes of Health
Grant: 5K12CA087723-23
Dana Farber/Harvard Cancer Consortium Career Development Program in Clinical Oncology
FWCI
0.00
Citation Percentile
0.2%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals